Birmingham, Ala.
Oxford Pharmaceuticals broke ground in September of 2015 on a $29.4 million manufacturing plant in Birmingham, Ala. Designed by NOLA Van Peursem Architects, the 120,000-sf facility is located in the Jefferson Metropolitan Park at Lakeshore and will support generic drug research, production, and packaging. The general contractor for the project is Robins & Morton. The facility is expected to become operational in the third quarter of 2016. Oxford Pharmaceuticals is based in the United Kingdom.
